We pioneer next-generation immunotherapy by blocking pro-tumoral immune activity. Our research uncovers how tumor cells, microbiota, and immune infiltrates drive hormone-dependent and BRCA-mutated cancers.
https://ior.usi.ch/group/cancer-immunotherapy